Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 464 results for "ranbaxy lab"

Ranbaxy Labs sues FDA
Reuters India

Ranbaxy Lab sues US FDA for revoking drug approvals

Last month, FDA told Ranbaxy that it believed its decisions to grant the company tentative approvals for copies of Nexium and Roche AG's antiviral Valcyte were "in error". Ranbaxy Laboratories Ltd has sued thUS Food and Drug Administration (FDA) for revoking ... India Infoline, 6 days ago
Ranbaxy Labs sues FDA Reuters India, 6 days ago

6 images for ranbaxy lab

Yahoo! News Australia, 6 days ago
Reuters India, 6 days ago
Sify, 1 month ago
Millennium Post, 3 weeks ago
Business Standard, 3 weeks ago
Millennium Post, 3 weeks ago

Ranbaxy Lab drops after reports of suing USFDA for revoking drug approvals

Ranbaxy Laboratories declined 2.03% to Rs 629.10 at 15:25 IST on BSE on reports company has sued the US Food and Drug Administration for revoking approvals granted to the firm to launch copies of two drugs. Meanwhile, the S&P BSE Sensex was down 24.44 points ...
 Business Standard6 days ago
New Indian Express

Angel Broking maintains neutral on Ranbaxy Lab

Ranbaxy Laboratories posted results better than expected on net sales and profits front. The company posted net sales of Rs 32.18 billion V/s Rs 27.5 billion, a yoy growth of 17%, mostly driven by the 180-day exclusivity of Valsartan. Commenting ...
 MyIris3 weeks ago Ranbaxy Lab jumps after turnaround in Q2  Business Standard3 weeks ago Ranbaxy Lab surges after turnaround Q2 results  Business Standard3 weeks ago Ranbaxy Back in Black with Rs 478 cr Profit  New Indian Express3 weeks ago
Business Standard

Pharma shares on roll; CNX Pharma index hits new high

Pharma, Ranbaxy Lab, Aurobindo, Glenmark Pharma, Strides Arcolab, Divi's Lab, Lupin and Cipla are up 1-6% on SI Reporter | Mumbai September 29, 2014 Last Updated at 11:00 IST Shares of pharmaceutical companies are on a roll with most of the frontline stocks ...
 Business Standard1 month ago Ranbaxy, Sun Pharma fall 4-5%; analysts say DRL to benefit  Moneycontrol.com2 weeks ago Dr Reddy's, MM, Maruti to get astro support: Gupta  Money Control1 month ago Pharma index hits new high  Business Standard India2 weeks ago

Ranbaxy Lab gains on settling litigation concerning Texas Medicaid Program

Ranbaxy Laboratories is currently trading at Rs. 601.75, up by 3.70 points or 0.62% from its previous closing of Rs. 598.05 on the BSE. The scrip opened at Rs. 598.00 and has touched a high and low of Rs. 604.50 and Rs. 596.25 respectively. So far ...
 Arihant Capital1 month ago Dr. Reddys Lab trades in pink of its health on BSE  Arihant Capital1 week ago

Ranbaxy Lab receives Civil Investigative Demand from United States Department of Justice

The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation. Ranbaxy Laboratories Ltd has announced that the Company has received a Civil Investigative Demand ("CID") from the United States Department ...
 India Infoline2 months ago Ranbaxy Labs. - Receipt of Civil Investigative Demand ("CID"...  SBICAP Securities2 months ago

CCI begins public scrutiny of Holcim-Lafarge deal

F This is the second public scrutiny of a M&A deal by the Competition Commission of India (CCI) after Ranbaxy - Sun Pharma merger. The comments with respect to the Holcim-Lafarge deal need to be submitted to the CCI (Competition Commission of ...
 Moneycontrol.com2 days ago CCI feels Sun-Ranbaxy deal may hit competition  Asian Age2 months ago CCI begins public scrutiny of Sun-Ranbaxy deal; seeks comments  Business Standard2 months ago CCI Invites Comments for Scrutiny of Sun-Ranbaxy Deal  Outlook2 months ago
Money Today

Dr Reddy's Lab's Visakhapatnam unit comes under USFDA lens

USFDA is conducting a surprise inspection of Dr Reddy's Laboratories Visakhapatnam plant. The US Food and Drug Administration (USFDA) is conducting a surprise inspection of Dr Reddy's Laboratories Visakhapatnam plant. The inspection, which ...
 Financial Express4 days ago Dr Reddy's gets FDA approval to launch antiviral drug  Money Today2 weeks ago Dr. Reddy's gets FDA nod for Roche drug generic  The Hindu2 weeks ago
NDTV Profit

Buy Reliance Industries, Sell Ranbaxy Today: Sanjeev Bhasin

Sanjeev Bhasin, independent market analyst Indian stock markets are likely to open flat on Monday as weak Japanese data led to weakness across Asian markets. Japan's Nikkei index fell nearly 2 per cent in morning trade today as the country ...
 NDTV Profit1 week ago Buy Tata Communications, Siemens India Today: Sanjeev Bhasin  NDTV Profit5 days ago Buy Tata Motors, Union Bank Today: Sanjeev Bhasin  NDTV Profit6 days ago

Buy IRB Infra, Ranbaxy, Adani Ports: Vishal B Malkan

I One can buy IRB Infrastructure for a target price of Rs 285 and keep a stoploss at Rs 257. One can buy Ranbaxy Labs for a target price of Rs 720 and keep a stoploss at Rs 655. One can buy Indiabulls Real Estate for a target price of Rs 82 and ...
 Moneycontrol.com1 week ago Bull's Eye: Buy Bharat Forge, Titan, OBC, Ranbaxy Labs  Money Control2 weeks ago Bull's Eye: Buy Bharat Forge, Ashok Leyland, Ranbaxy Labs  Money Control1 week ago Accumulate Ranbaxy Labs; target of Rs 670: KRChoksey  Money Control2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less